GLP-1 receptor agonists have changed the conversation around weight management more dramatically than any class of medication in decades. Tirzepatide and semaglutide, the active compounds behind Mounjaro, Zepbound, Ozempic, and Wegovy, produce weight loss outcomes once achievable only through bariatric surgery. Clinical trials have shown total body weight reductions of 15 to 22 percent, and for millions of people living with obesity or metabolic disease, that is genuinely lif

Understanding the KwikPen Mechanism The Mounjaro KwikPen is currently the most advanced tool for medical weight loss available in the Philippines. If you are on our Shape Ultra Pro protocol, you are likely using Tirzepatide to target two distinct pathways: GLP-1 and GIP. Most people know GLP-1 for appetite suppression, but the GIP component is what makes Mounjaro different. It improves how your body breaks down sugar and fats. The KwikPen delivers this via a weekly dose tha